GERD: Reflux to Esophageal Adenocarcinoma
Gastroesophageal Reflux Disease (GERD) is one of the most common maladies of mankind. Approximately 40% of the adult population of the USA suffers from significant heartburn and the numerous antacids advertised incessantly on national television represents a $8 billion per year drug market. The ability to control acid secretion with the increasingly effective acid-suppressive agents such as the H2 blockers (pepcid, zantac) and proton pump inhibitors (nexium, prevacid) has given physicians an excellent method of treating the symptoms of acid reflux.

Unfortunately, this has not eradicated reflux disease. It has just changed its nature. While heartburn, ulceration and strictures have become rare, reflux-induced adenocarcinoma of the esophagus is becoming increasingly common. Adenocarcinoma of the esophagus and gastric cardia is now the most rapidly increasing cancer type in the Western world.

The increasing incidence of esophageal adenocarcinoma has created an enormous interest and stimulus for research in this area. GERD brings together a vast amount of disparate literature and presents the entire pathogenesis of reflux disease in one place. In addition to providing a new concept of how gastroesophageal reflux causes cellular changes in the esophagus, GERD also offers a complete solution to a problem that has confused physicians for over a century. Both clinical and pathological information about reflux disease and its treatment are presented. GERD is meant to be used as a comprehensive reference for gastroenterologists, esophageal surgeons, and pathologists alike.
  • Outlines how gastroesophageal reflux causes cellular changes in the esophagus
  • Brings together the pathogenesis of the disease in one source and applies it toward clinical treatment
  • Tom DeMeester is THE leading international expert on reflux disease; Parakrama Chandrasoma is one of the leading pathologists in the area
  • Book contains approximately 350 illustrations
  • Ancillary web site features color illustrations: www.chandrasoma.com
1111341011
GERD: Reflux to Esophageal Adenocarcinoma
Gastroesophageal Reflux Disease (GERD) is one of the most common maladies of mankind. Approximately 40% of the adult population of the USA suffers from significant heartburn and the numerous antacids advertised incessantly on national television represents a $8 billion per year drug market. The ability to control acid secretion with the increasingly effective acid-suppressive agents such as the H2 blockers (pepcid, zantac) and proton pump inhibitors (nexium, prevacid) has given physicians an excellent method of treating the symptoms of acid reflux.

Unfortunately, this has not eradicated reflux disease. It has just changed its nature. While heartburn, ulceration and strictures have become rare, reflux-induced adenocarcinoma of the esophagus is becoming increasingly common. Adenocarcinoma of the esophagus and gastric cardia is now the most rapidly increasing cancer type in the Western world.

The increasing incidence of esophageal adenocarcinoma has created an enormous interest and stimulus for research in this area. GERD brings together a vast amount of disparate literature and presents the entire pathogenesis of reflux disease in one place. In addition to providing a new concept of how gastroesophageal reflux causes cellular changes in the esophagus, GERD also offers a complete solution to a problem that has confused physicians for over a century. Both clinical and pathological information about reflux disease and its treatment are presented. GERD is meant to be used as a comprehensive reference for gastroenterologists, esophageal surgeons, and pathologists alike.
  • Outlines how gastroesophageal reflux causes cellular changes in the esophagus
  • Brings together the pathogenesis of the disease in one source and applies it toward clinical treatment
  • Tom DeMeester is THE leading international expert on reflux disease; Parakrama Chandrasoma is one of the leading pathologists in the area
  • Book contains approximately 350 illustrations
  • Ancillary web site features color illustrations: www.chandrasoma.com
99.49 In Stock
GERD: Reflux to Esophageal Adenocarcinoma

GERD: Reflux to Esophageal Adenocarcinoma

by Parakrama T. Chandrasoma MD, Tom R. DeMeester
GERD: Reflux to Esophageal Adenocarcinoma

GERD: Reflux to Esophageal Adenocarcinoma

by Parakrama T. Chandrasoma MD, Tom R. DeMeester

eBook

$99.49  $132.00 Save 25% Current price is $99.49, Original price is $132. You Save 25%.

Available on Compatible NOOK devices, the free NOOK App and in My Digital Library.
WANT A NOOK?  Explore Now

Related collections and offers


Overview

Gastroesophageal Reflux Disease (GERD) is one of the most common maladies of mankind. Approximately 40% of the adult population of the USA suffers from significant heartburn and the numerous antacids advertised incessantly on national television represents a $8 billion per year drug market. The ability to control acid secretion with the increasingly effective acid-suppressive agents such as the H2 blockers (pepcid, zantac) and proton pump inhibitors (nexium, prevacid) has given physicians an excellent method of treating the symptoms of acid reflux.

Unfortunately, this has not eradicated reflux disease. It has just changed its nature. While heartburn, ulceration and strictures have become rare, reflux-induced adenocarcinoma of the esophagus is becoming increasingly common. Adenocarcinoma of the esophagus and gastric cardia is now the most rapidly increasing cancer type in the Western world.

The increasing incidence of esophageal adenocarcinoma has created an enormous interest and stimulus for research in this area. GERD brings together a vast amount of disparate literature and presents the entire pathogenesis of reflux disease in one place. In addition to providing a new concept of how gastroesophageal reflux causes cellular changes in the esophagus, GERD also offers a complete solution to a problem that has confused physicians for over a century. Both clinical and pathological information about reflux disease and its treatment are presented. GERD is meant to be used as a comprehensive reference for gastroenterologists, esophageal surgeons, and pathologists alike.
  • Outlines how gastroesophageal reflux causes cellular changes in the esophagus
  • Brings together the pathogenesis of the disease in one source and applies it toward clinical treatment
  • Tom DeMeester is THE leading international expert on reflux disease; Parakrama Chandrasoma is one of the leading pathologists in the area
  • Book contains approximately 350 illustrations
  • Ancillary web site features color illustrations: www.chandrasoma.com

Product Details

ISBN-13: 9780080464749
Publisher: Elsevier Science
Publication date: 07/26/2010
Sold by: Barnes & Noble
Format: eBook
Pages: 464
File size: 49 MB
Note: This product may take a few minutes to download.

About the Author

Dr. Parakrama Chandrasoma was born in Sri Lanka and received his medical education and initial pathology training in the Medical School of the University of Sri Lanka. He has postgraduate degrees in internal medicine, including the M.D. (Sri Lanka) and Membership of the Royal College of Physicians (UK). He immigrated to the United States in 1978. Upon completing his pathology residency, he assumed duties as Chief of Surgical Pathology at the Los Angeles County + University of Southern California Medical Center He has held this position since. After an initial interest in neuropathology, Dr. Chandrasoma joined Dr. Tom DeMeester’s Foregut Surgery team as pathologist in 1991. This led to a productive study of gastroesophageal reflux disease spanning 16 years and resulting in the development of numerous original concepts relating to the pathogenesis of gastroesophageal reflux disease. Dr. Chandrasoma has written over 140 peer reviewed papers and 6 previous pathology textbooks, including a general text on Gastrointestinal Pathology and a text on Gastroesophageal Reflux Disease, and is a Professor of Pathology at the Keck School of Medicine at the University of Southern California. He is married with three children and lives in Pasadena, California.
Professor of Clinical Surgery and Chair of the Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Table of Contents

Chapter 1: Overview of Gastroesophageal Reflux Disease

Chapter 2: The Past, Present, and Future of Columnar-Lined (Barrett) Esophagus

Chapter 3: Fetal Development of the Esophagus and Stomach

Chapter 4: Normal Anatomy; Present Definition of the Gastroesophageal Junction

Chapter 5: Histologic Definitions and Diagnosis of Epithelial Types

Chapter 6: Cardiac Mucosa

Chapter 7: New Histologic Definitions of Esophagus, Stomach, and Gastroesophageal Junction

Chapter 8: Pathology of Reflux Disease at a Cellular Level: Part 1—Damage to Squamous Epithelium and Transformation into Cardiac Mucosa

Chapter 9: The Pathology of Reflux Disease at a Cellular Level: Part 2—Evolution of Cardiac Mucosa to Oxyntocardiac Mucosa and Intestinal Metaplasia

Chapter 10: Pathology of Reflux Disease at a Cellular Level: Part 3—Intestinal (Barrett) Metaplasia to Carcinoma

Chapter 11: Pathology of Reflux Disease at an Anatomic Level

Chapter 12: Reflux Disease Limited to the Dilated End-Stage Esophagus: The Pathologic Basis of NERD

Chapter 13: Definition of Gastroesophageal Reflux Disease and Barrett Esophagus

Chapter 14: Diagnosis of Gastroesophageal Reflux Disease, Barrett Esophagus, and Dysplasia

Chapter 15: Research Strategies for Preventing Reflux-Induced Adenocarcinoma

Chapter 16: Rationale for Treatment of Reflux Disease and Barrett Esophagus

Chapter 17: Treatment Strategies for Preventing Reflux-Induced Adenocarcinoma

Index

What People are Saying About This

From the Publisher

This text provides both clinical and pathological information about GERD and its treatment.

From the B&N Reads Blog

Customer Reviews